Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
HPV InfectionSystemic Disease
Interventions
PROCEDURE

Vaginal self sampling detecting HPV

IMIDs patients who are not up to date with CCS be included into the study to perform a vaginal self-screening (VSS) A positive VSS will be confirmed by a standard HPV test and management of the results of standard HPV test or VSS will be performed as planned following HAS guidelines. For women with a positive VSS, follow-up results (HPV test and cytology, biopsy, etc.) will be collected according to the usual procedures of the screening facility and in accordance with the recommendations of the Health authorities

Trial Locations (1)

75018

RECRUITING

Service de Médecine Interne - Hôpital Bichat Claude Bernard, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER